HomeNewsIndiaCoronavirus vaccine | Current production not enough, will take 4-5 years to vaccinate everyone, says Adar Poonawalla

Coronavirus vaccine | Current production not enough, will take 4-5 years to vaccinate everyone, says Adar Poonawalla

CEO of Serum Institute Adar Poonawalla said also raised concerns about vaccine distribution in India given the country’s poor cold chain infrastructure to transport the vaccine safely

September 14, 2020 / 19:30 IST
Story continues below Advertisement


Adar Poonawalla, CEO of the Serum Institute of India (SII) has warned of shortage of the COVID-19 vaccine for all till 2024 at least.

Pharmaceutical companies are not increasing production capacity quickly enough to inoculate the global population immediately, adding that it would take four to five years until “everyone on the planet” gets vaccinated, he told the Financial Times.

Story continues below Advertisement

Poonawalla estimated a need for close to 15 billion doses of the COVID-19 vaccine if a two-dose programme – similar to the measles vaccinations drive is initiated.

He also raised concerns about vaccine distribution in India given the country’s poor cold chain infrastructure to transport the vaccine safely to its 1.4 billion people.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show